GC
BSTG

Guggenheim Capital’s Biostage, Inc. Common Stock BSTG Stock Holding History

Guggenheim Capital’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-49,973
Closed -$163K – 3133
2015
Q1 		$163K Sell
49,973
-2,584
-5% -$8.8K ﹤0.01% 2817
2014
Q4 		$167K Sell
52,557
-16,810
-24% -$83.3K ﹤0.01% 2813
2014
Q3 		$562K Sell
69,367
-9,229
-12% -$75.5K ﹤0.01% 2508
2014
Q2 		$821K Buy
+78,596
New +$669K ﹤0.01% 2372

Other funds holding BSTG

State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
WIC
Woodmont Investment Counsel Nashville, Tennessee $1.62B AUM 18.92% 1-Year Est. Return

Guggenheim Capital's BSTG Position: Q2 2015 in Review

Guggenheim Capital sold out of Biostage, Inc. Common Stock (BSTG) in Q2 2015, closing a stake of 49,973 shares — an estimated $163K sold.

Guggenheim Capital first reported a position in BSTG in Q2 2014 and held it in 4 quarters. The position peaked at $821K in Q2 2014. 32 funds tracked by Wall St. Rank hold BSTG as of Q2 2015.

  • Guggenheim Capital reported no remaining Biostage, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
  • Guggenheim Capital sold 49,973 Biostage, Inc. Common Stock shares in Q2 2015, an estimated $163K.
  • Guggenheim Capital first reported a position in Biostage, Inc. Common Stock in Q2 2014 and held it in 4 quarters.
  • Guggenheim Capital's Biostage, Inc. Common Stock position peaked at $821K in Q2 2014.
  • 32 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q2 2015.

Based on Guggenheim Capital's 13F filing for Q2 2015, filed 14 Aug 2015.